These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 27091114)

  • 1. CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis.
    Olmes G; Büttner-Herold M; Ferrazzi F; Distel L; Amann K; Daniel C
    Arthritis Res Ther; 2016 Apr; 18():90. PubMed ID: 27091114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage subpopulations in pediatric patients with lupus nephritis and other inflammatory diseases affecting the kidney.
    Sandersfeld M; Büttner-Herold M; Ferrazzi F; Amann K; Benz K; Daniel C
    Arthritis Res Ther; 2024 Feb; 26(1):46. PubMed ID: 38331818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus nephritis: correlation of immunohistochemical expression of C4d, CD163-positive M2c-like macrophages and Foxp3-expressing regulatory T cells with disease activity and chronicity.
    Allam M; Fathy H; Allah DA; Salem MAE
    Lupus; 2020 Jul; 29(8):943-953. PubMed ID: 32580679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2a and M2b macrophages predominate in kidney tissues and M2 subpopulations were associated with the severity of disease of IgAN patients.
    Hu W; Lin J; Lian X; Yu F; Liu W; Wu Y; Fang X; Liang X; Hao W
    Clin Immunol; 2019 Aug; 205():8-15. PubMed ID: 31078708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-mediated M2/M1 macrophage polarization may be involved in crescent formation in lupus nephritis.
    Tao J; Zhao J; Qi XM; Wu YG
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108278. PubMed ID: 34700131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of M2 macrophages in glomerulonephritis with crescents.
    Li J; Yu YF; Liu CH; Wang CM
    Pathol Res Pract; 2017 Sep; 213(9):1215-1220. PubMed ID: 28554749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between tubulointerstitial CD8+T cells and renal prognosis in lupus nephritis.
    Zhang T; Wang M; Zhang J; Feng X; Liu Z; Cheng Z
    Int Immunopharmacol; 2021 Oct; 99():107877. PubMed ID: 34217995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis.
    Endo N; Tsuboi N; Furuhashi K; Shi Y; Du Q; Abe T; Hori M; Imaizumi T; Kim H; Katsuno T; Ozaki T; Kosugi T; Matsuo S; Maruyama S
    Nephrol Dial Transplant; 2016 Dec; 31(12):2023-2033. PubMed ID: 27242373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of CD163-Positive Macrophages in Proliferative Glomerulonephritis.
    Li J; Liu CH; Xu DL; Gao B
    Am J Med Sci; 2015 Nov; 350(5):387-92. PubMed ID: 26379042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognosis and pathogenesis of severe lupus glomerulonephritis.
    Schwartz MM; Korbet SM; Lewis EJ;
    Nephrol Dial Transplant; 2008 Apr; 23(4):1298-306. PubMed ID: 18045825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of repeat biopsy in the management of lupus nephritis: an international multicentre study in a large cohort of patients.
    Pagni F; Galimberti S; Goffredo P; Basciu M; Malachina S; Pilla D; Galbiati E; Ferrario F
    Nephrol Dial Transplant; 2013 Dec; 28(12):3014-23. PubMed ID: 23975838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages.
    Barros MH; Hauck F; Dreyer JH; Kempkes B; Niedobitek G
    PLoS One; 2013; 8(11):e80908. PubMed ID: 24260507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of Th1 immune response in diffuse proliferative lupus nephritis.
    Masutani K; Akahoshi M; Tsuruya K; Tokumoto M; Ninomiya T; Kohsaka T; Fukuda K; Kanai H; Nakashima H; Otsuka T; Hirakata H
    Arthritis Rheum; 2001 Sep; 44(9):2097-106. PubMed ID: 11592372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.
    Ma R; Jiang W; Li Z; Sun Y; Wei Z
    Lupus; 2016 Dec; 25(14):1577-1586. PubMed ID: 27147620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
    Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
    PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.
    Mejia-Vilet JM; Zhang XL; Cruz C; Cano-Verduzco ML; Shapiro JP; Nagaraja HN; Morales-Buenrostro LE; Rovin BH
    J Am Soc Nephrol; 2020 Jun; 31(6):1335-1347. PubMed ID: 32300067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular macrophage is an indicator of early treatment response in diffuse proliferative lupus nephritis.
    Cheunsuchon B; Incharoen P; Chawanasuntorapoj R; Chanchairujira T; Shayakul C
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S246-51. PubMed ID: 23590049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of serial kidney biopsies in lupus nephritis.
    Alsuwaida AO
    Mod Rheumatol; 2014 May; 24(3):453-6. PubMed ID: 24251991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages.
    Hill GS; Delahousse M; Nochy D; Rémy P; Mignon F; Méry JP; Bariéty J
    Kidney Int; 2001 Jan; 59(1):304-16. PubMed ID: 11135084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.